IFRX CIK: 1708688

InflaRx N.V.

  • Germany
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions EUR
FY21:
95.7
FY22:
97.4
FY23:
109
FY24:
71.7
FY25:
53.6
(positive)
Change from FY21 to FY25
millions EUR
FY21:
29.5
FY22:
4.99
FY23:
10.7
FY24:
4.36
FY25:
1.58
Total assets
Change from FY21 to FY25
millions EUR
FY21:
125
FY22:
102
FY23:
120
FY24:
76.0
FY25:
55.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions EUR
FY21:
18.8
FY22:
13.0
FY23:
16.8
FY24:
14.2
FY25:
13.0
(negative)
Change from FY21 to FY25
millions EUR
FY21:
1.10
FY22:
1.02
FY23:
0.78
FY24:
0.44
FY25:
0.68
(positive)
Change from FY21 to FY25
millions EUR
FY21:
105
FY22:
88.3
FY23:
103
FY24:
61.4
FY25:
41.6
Total liabilities & equity
Change from FY21 to FY25
millions EUR
FY21:
125
FY22:
102
FY23:
120
FY24:
76.0
FY25:
55.2

All amounts in millions EUR Data source:SEC EDGAR